Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microcirculation and arterial hypertension.

E Vicaut1

  • 1Laboratory for the Study of Microcirculation, F. Widal Hospital, Paris, France.

Drugs
|October 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early onset radiation-induced leukoencephalopathy in patients treated for a glioblastoma by STUPP protocol and risk factors evaluation, an ancillary study of the phase III ASTER protocol.

Revue neurologique·2026
Same author

COVID-19 and chronic liver disease: results from the 1219 patients French registry.

Scientific reports·2025
Same author

Subcutaneous Infliximab for Perianal Crohn's Disease: The BioLap-Rem Multicenter Study From the GETAID.

The American journal of gastroenterology·2025
Same author

A multicentre pragmatic randomized controlled trial comparing 50% salicylic acid, liquid nitrogen, 5% 5-fluorouracil cream, and 5% imiquimod cream in previously treated plantar warts. The VRAIE (VeRrues plAntaIres en villE) study.

Annales de dermatologie et de venereologie·2025
Same author

Nailfold capillaroscopy in acrocyanosis among patients with associated Raynaud's phenomenon.

Annales de dermatologie et de venereologie·2024
Same author

A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis.

Journal of neurology·2023
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
Same journal

Linerixibat: First Approval.

Drugs·2026
See all related articles

Hypertension significantly alters the microvascular network, increasing vasoconstriction and decreasing dilation. This microvascular rarefaction, affecting arterioles and capillaries, is a key target for antihypertensive drug development.

Area of Science:

  • Cardiovascular Research
  • Hypertension Pathophysiology
  • Microcirculation

Background:

  • The microvascular network, comprising vessels <150 microns, is crucial for peripheral resistance.
  • Hypertension profoundly impacts microvascular function and structure, particularly arterioles.

Purpose of the Study:

  • To review functional and structural changes in the microvasculature during hypertension.
  • To highlight microvascular rarefaction as a key pathological feature and therapeutic target.

Main Methods:

  • Review of existing literature on microvascular alterations in hypertensive models and patients.
  • Analysis of functional changes (vasoconstriction, dilation) and structural changes (rarefaction).

Main Results:

Related Experiment Videos

  • Hypertension increases arteriolar sensitivity to vasoconstrictors and reduces endothelium-dependent dilation.
  • Myogenic responses are amplified in hypertension via prostanoid and endothelin pathways.
  • Microvascular rarefaction, both functional and anatomical, is a common structural change in hypertension.

Conclusions:

  • The microvascular network is both a cause and a target of hypertension.
  • Antihypertensive strategies should consider their impact on reversing microcirculatory damage.